KR920701297A - 에폭시드 화합물의 중합방법 - Google Patents

에폭시드 화합물의 중합방법

Info

Publication number
KR920701297A
KR920701297A KR1019910701562A KR910701562A KR920701297A KR 920701297 A KR920701297 A KR 920701297A KR 1019910701562 A KR1019910701562 A KR 1019910701562A KR 910701562 A KR910701562 A KR 910701562A KR 920701297 A KR920701297 A KR 920701297A
Authority
KR
South Korea
Prior art keywords
metal complex
natural number
lewis
weight
parts
Prior art date
Application number
KR1019910701562A
Other languages
English (en)
Other versions
KR970001539B1 (ko
Inventor
악셀 뵈트허
에곤 우리히
만프레드 훼드케
만프레드 되링
크라우스 다테
베른드 네슬러
Original Assignee
게르하르트빌헬름 및 만프레드마인브렉세
뤼트거스벨케 악틴게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DD90338525A external-priority patent/DD293126A5/de
Priority claimed from DD90338526A external-priority patent/DD292468A5/de
Application filed by 게르하르트빌헬름 및 만프레드마인브렉세, 뤼트거스벨케 악틴게젤샤프트 filed Critical 게르하르트빌헬름 및 만프레드마인브렉세
Publication of KR920701297A publication Critical patent/KR920701297A/ko
Application granted granted Critical
Publication of KR970001539B1 publication Critical patent/KR970001539B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
    • C08G59/70—Chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208—Oxygen, e.g. acetylacetonates
    • B01J31/2226—Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
    • B01J31/223—At least two oxygen atoms present in one at least bidentate or bridging ligand
    • B01J31/2234—Beta-dicarbonyl ligands, e.g. acetylacetonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L63/00—Compositions of epoxy resins; Compositions of derivatives of epoxy resins
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J163/00—Adhesives based on epoxy resins; Adhesives based on derivatives of epoxy resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/10—Polymerisation reactions involving at least dual use catalysts, e.g. for both oligomerisation and polymerisation
    • B01J2231/14—Other (co) polymerisation, e.g. of lactides, epoxides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84—Metals of the iron group
    • B01J2531/842—Iron
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84—Metals of the iron group
    • B01J2531/845—Cobalt
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84—Metals of the iron group
    • B01J2531/847—Nickel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epoxy Resins (AREA)
  • Polyethers (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerization Catalysts (AREA)
  • Polymerisation Methods In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

내용 없음

Description

에폭시드 화합물의 중합방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (13)

  1. 반응을 촉진하는 루이스-베이스를 사용하는 에폭시드 화합물의 중합을 위한 방법에 있어서, 일반식 MLxBy, 또는 M〔SR〕xBz의 금속착화합물의 0.01 내지 50중량부를 가지는 에폭시드 화합물의 100중량부가 화합되며 그리고 에너지가 공급되며, 여기서 -M은 금속이온, -L은 리간드, -SR은 산의 잔여이온, -B는 루이스-베이스, -x는 1부터 8까지의 범위에 있는 자연수, -y는 1부터 5까지의 범위에 있는 자연수, -z는 7부터 8까지의 범위에 있는 자연수인 것을 특징으로 하는 방법.
  2. 제1항에 있어서, 리간드로서 벤조일아세토네이트 또는 디피발로일메탄을 포함하는 금속착화합물이 사용되는 것을 특징으로 하는 방법.
  3. 제1항에 있어서, 리간드로서 아세틸아세톤 또는 임의의 지방족 또는 방향족 탄산을 포함하는 금속착화합물이 사용되는 것을 특징으로 하는 방법.
  4. 제1항 내지 제3항 중의 어느 하나의 항에 있어서, 금속이온으로서 코발트-, 닉켈-, 철-, 아연-, 또는 망간-이온들을 함유하는 금속착화합물이 사용되는 것을 특징으로 하는 방법.
  5. 제1항 내지 제4항 중의 어느 하나의 항에 있어서, 루이스-베이스로서, 피리딘, 이미다졸, 테트라하이드로퓨란, 알콜, 케톤, 티오에테르 또는 머캡탄을 포함하는 금속착화합물이 사용되는 것을 특징으로 하는 방법.
  6. 제1항 내지 제4항 중의 어느 하나의 항에 있어서, 루이스-베이스로서, CH-산의 피리딘, 마론산디에스테르 또는 -디니트릴, 아세트초산에스테르, 시안초산에스테르 또는 니트로메탄을 포함하는 금속착화합물이 사용되는 것을 특징으로 하는 방법.
  7. 에폭시드화합물들 및 다수의 루이스-베이스의 혼합물들에 있어서, 이들은 하나의 또는 다수의 에폭시드 화합물의 100중량부를 그리고 일반식 MLxBy, 또는 M〔SR〕xBz의 금속착화합물의 0.01 내지 50중량부를 포함하며, 여기서 -M은 금속이온, -L은 리간드, -SR은 산의 잔여이온, -B는 루이스-베이스, -x는 1부터 8까지의 범위에 있는 자연수, -y는 1부터 5까지의 범위에 있는 자연수, -z는 7부터 8까지의 범위에 있는 자연수인 것을 특징으로 하는 혼합물.
  8. 제7항에 있어서, 이 혼합물들은 100중량부 에폭시드화합물에서 금속착화합물의 1 내지 10중량부를 함유하는 것을 특징으로 하는 혼합물.
  9. 접착-및 밀봉재료의 제조를 위한 청구범위 제7항 및 제8항 중의 하나의 항에 의한 혼합물의 이용.
  10. 형재료엣의 결합제로서 청구범위 제7항 및 제8항 중의 하나의 항에 의한 혼합물의 이용.
  11. 전기-또는 전자 범위에서 고가의 주입재료를 위한 점결제로서 청구범위 제7항 및 제8항의 하나의 항에 의한 혼합물 이용.
  12. 전기적인 도체판의 제조를 위한 청구범위 제7항 및 제8항 중의 하나의 항에 의한 혼합물들의 이용.
  13. 강력결합 가공재료의 제조를 위한 청구범위 제7항 및 제8항 중의 하나의 항에 의한 혼합물들의 이용.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910701562A 1990-03-09 1991-03-06 에폭시드 화합물의 중합 방법 KR970001539B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DD90338525A DD293126A5 (de) 1990-03-09 1990-03-09 Verfahren zur polymerisation von epoxidischen verbindungen
DEWP338526-5 1990-03-09
DD90338526A DD292468A5 (de) 1990-03-09 1990-03-09 Verfahren zur polymerisation von epoxidverbindungen
DEWP338525-7 1990-03-09
PCT/EP1991/000419 WO1991013925A1 (de) 1990-03-09 1991-03-06 Verfahren zur polymerisation von epoxidverbindungen

Publications (2)

Publication Number Publication Date
KR920701297A true KR920701297A (ko) 1992-08-11
KR970001539B1 KR970001539B1 (ko) 1997-02-11

Family

ID=25748335

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910701562A KR970001539B1 (ko) 1990-03-09 1991-03-06 에폭시드 화합물의 중합 방법

Country Status (11)

Country Link
EP (1) EP0518908B1 (ko)
JP (1) JP3215106B2 (ko)
KR (1) KR970001539B1 (ko)
AT (1) ATE119174T1 (ko)
BR (1) BR9104778A (ko)
CA (1) CA2054212C (ko)
DE (1) DE59104812D1 (ko)
ES (1) ES2036162T3 (ko)
GR (1) GR920300130T1 (ko)
LV (1) LV10116B (ko)
WO (1) WO1991013925A1 (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4207258A1 (de) * 1992-03-07 1993-09-09 Ruetgerswerke Ag Schleifmittel
DE4208518A1 (de) * 1992-03-17 1993-09-23 Ruetgerswerke Ag Hochtemperaturbestaendige elektro-laminate, verfahren zu ihrer herstellung und verwendung
DE4303824A1 (de) * 1993-02-10 1994-08-11 Ruetgerswerke Ag Epoxidharzsystem
DE4408865C2 (de) * 1994-03-16 2001-05-17 Raymond A & Cie Verwendung einer einkomponentigen, adhäsiven Beschichtungsmasse zum Ausrüsten der Oberflächen von Befestigungselementen mit einer reaktiven Klebschicht
EP0682053B1 (de) * 1994-05-10 2002-10-23 Vantico AG Metallkomplexkatalysatoren enthaltende Epoxidharzgemische
DE4421623A1 (de) * 1994-06-21 1996-01-04 Thera Ges Fuer Patente Mehrkomponentige, kationisch härtende Epoxidmassen und deren Verwendung sowie Verfahren zur Herstellung gehärteter Massen
DE19905448A1 (de) * 1999-02-09 2000-08-10 Bakelite Ag Cyanatharze und Epoxidverbindungen enthaltende härtbare Mischungen
DE19910711A1 (de) * 1999-03-10 2000-09-14 Bakelite Ag Imprägniervergußmassen, ihre Verwendung sowie ein Verfahren zur Imprägnierung von Zündspulen
DE10113940A1 (de) * 2001-03-22 2002-09-26 Bakelite Ag Verfahren zur Herstellung von mit Harz behandelten Verstärkungs- oder Kaschiermaterialien
CA2465958A1 (en) * 2001-11-05 2003-05-15 Fiberspar Corporation Spoolable composite tubing with a catalytically cured matrix
CA2641492C (en) 2007-10-23 2016-07-05 Fiberspar Corporation Heated pipe and methods of transporting viscous fluid
CA2690926C (en) 2009-01-23 2018-03-06 Fiberspar Corporation Downhole fluid separation
US8955599B2 (en) 2009-12-15 2015-02-17 Fiberspar Corporation System and methods for removing fluids from a subterranean well
US9206676B2 (en) 2009-12-15 2015-12-08 Fiberspar Corporation System and methods for removing fluids from a subterranean well
WO2014026190A1 (en) 2012-08-10 2014-02-13 National Oilwell Varco, L.P. Composite coiled tubing connectors
DE102014102455A1 (de) * 2014-02-25 2015-08-27 Seho Systemtechnik Gmbh Verfahren zum Polymerisieren von einem Kunstharz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3310602A (en) * 1962-07-26 1967-03-21 Borden Co Curing epoxide resins with aromatic amine-aldehyde coordination complexes
US3367913A (en) * 1966-09-09 1968-02-06 Interchem Corp Thermosetting epoxy resin composition containing a zinc chelate
US3677978A (en) * 1971-08-23 1972-07-18 Ppg Industries Inc Metal salt complexes of imidazoles as curing agents for one-part epoxy resins
GB1435540A (en) * 1972-07-06 1976-05-12 Mccall Corp Curable solventless composition
CH629230A5 (de) * 1977-11-04 1982-04-15 Ciba Geigy Ag Verfahren zur herstellung von metallsalz-aminkomplexen und ihre verwendung.
GB8304581D0 (en) * 1983-02-18 1983-03-23 Secr Defence Curing agents for epoxy resins
US4473674A (en) * 1983-11-03 1984-09-25 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Process for improving mechanical properties of epoxy resins by addition of cobalt ions

Also Published As

Publication number Publication date
KR970001539B1 (ko) 1997-02-11
BR9104778A (pt) 1992-03-24
LV10116B (en) 1995-02-20
CA2054212C (en) 1997-02-11
LV10116A (lv) 1994-05-10
EP0518908A1 (de) 1992-12-23
CA2054212A1 (en) 1991-09-10
JP3215106B2 (ja) 2001-10-02
DE59104812D1 (de) 1995-04-06
GR920300130T1 (en) 1993-03-16
ES2036162T1 (es) 1993-05-16
EP0518908B1 (de) 1995-03-01
ATE119174T1 (de) 1995-03-15
JPH05504593A (ja) 1993-07-15
WO1991013925A1 (de) 1991-09-19
ES2036162T3 (es) 1995-05-16

Similar Documents

Publication Publication Date Title
KR920701297A (ko) 에폭시드 화합물의 중합방법
ES419253A1 (es) Procedimiento para la preparacion de revestimientos mejora-dos de la resistencia a la corrsion de las superficies de objetos industriales.
ES478146A1 (es) Procedimiento para la preparacion de una composicion de re- sina de poli (tereftalato de etileno).
ES398231A1 (es) Un procedimiento para la fabricacion de composiciones de revestimiento termoendurecibles.
ES375951A1 (es) Un procedimiento para la preparacion de una composicion para revestimiento.
ES8300735A1 (es) Un procedimiento para la preparacion de derivados de acidos fenil-alcanoicos.
ES332921A1 (es) Procedimiento para la preparacion de un material poliester.
SE7602251L (sv) Omettade organiska kiselforeningar innehallande ketogrupper
JPS57174357A (en) Paint composition
JPS5440831A (en) Resin composition for matte powder coating
ES375853A1 (es) Procedimiento para la preparacion de composiciones de per- fume.
ES519621A0 (es) Procedimiento para la obtencion de polimeros conteniendo grupos carboxilo reactivos.
ES8707754A1 (es) Un procedimiento para preparar pinturas a base de zinc
GB1513769A (en) Epoxy resin-polyester coating compositions and their use
GB960622A (en) Novel amino esters and their use in epoxide resin compositions
ES301847A1 (es) Procedimiento de estabilizacion de polimeros de olefinas.
ES407059A1 (es) Procedimiento para preparar compuestos de organoestano.
JPS5665023A (en) Curable resin composition
JPS5721465A (en) Resin composition for powder paint
JPS56143214A (en) Epoxy resin composition
JPS5552342A (en) Polyethylene terephthalate resin molding compound having excellent mar resistance
JPS5665022A (en) Curable resin composition
ES319052A1 (es) El procedimiento para la preparacion de poliuretano celular.
ES288799A1 (es) Procedimiento para preparar nuevos quelatos metálicos con grupos epóxidos
ES330881A1 (es) Procedimiento para preparar una resina estable al calor y a la luz.

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040203

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee